147 related articles for article (PubMed ID: 6205817)
1. Quantitation of types I and III collagen in biopsy lung samples from patients with cryptogenic fibrosing alveolitis.
Kirk JM; Heard BE; Kerr I; Turner-Warwick M; Laurent GJ
Coll Relat Res; 1984 May; 4(3):169-82. PubMed ID: 6205817
[TBL] [Abstract][Full Text] [Related]
2. Cryptogenic fibrosing alveolitis: prediction of fibrogenic activity from immunohistochemical studies of collagen types in lung biopsy specimens.
Bateman ED; Turner-Warwick M; Haslam PL; Adelmann-Grill BC
Thorax; 1983 Feb; 38(2):93-101. PubMed ID: 6344313
[TBL] [Abstract][Full Text] [Related]
3. Circulating antibodies to lung protein(s) in patients with cryptogenic fibrosing alveolitis.
Wallace WA; Roberts SN; Caldwell H; Thornton E; Greening AP; Lamb D; Howie SE
Thorax; 1994 Mar; 49(3):218-24. PubMed ID: 8202877
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus replication within pulmonary epithelial cells in cryptogenic fibrosing alveolitis.
Egan JJ; Stewart JP; Hasleton PS; Arrand JR; Carroll KB; Woodcock AA
Thorax; 1995 Dec; 50(12):1234-9. PubMed ID: 8553293
[TBL] [Abstract][Full Text] [Related]
5. Serum type III procollagen peptide concentration in cryptogenic fibrosing alveolitis and its clinical relevance.
Kirk JM; Bateman ED; Haslam PL; Laurent GJ; Turner-Warwick M
Thorax; 1984 Oct; 39(10):726-32. PubMed ID: 6495240
[TBL] [Abstract][Full Text] [Related]
6. Biochemical evidence for an increased and progressive deposition of collagen in lungs of patients with pulmonary fibrosis.
Kirk JM; Da Costa PE; Turner-Warwick M; Littleton RJ; Laurent GJ
Clin Sci (Lond); 1986 Jan; 70(1):39-45. PubMed ID: 3943276
[TBL] [Abstract][Full Text] [Related]
7. High resolution computed tomographic assessment of asbestosis and cryptogenic fibrosing alveolitis: a comparative study.
al-Jarad N; Strickland B; Pearson MC; Rubens MB; Rudd RM
Thorax; 1992 Aug; 47(8):645-50. PubMed ID: 1412123
[TBL] [Abstract][Full Text] [Related]
8. Different cytokine profiles in cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis: a quantitative study of open lung biopsies.
Majumdar S; Li D; Ansari T; Pantelidis P; Black CM; Gizycki M; du Bois RM; Jeffery PK
Eur Respir J; 1999 Aug; 14(2):251-7. PubMed ID: 10515397
[TBL] [Abstract][Full Text] [Related]
9. Type III and type I procollagen markers in fibrosing alveolitis.
Lammi L; Ryhänen L; Lakari E; Risteli J; Pääkkö P; Kahlos K; Lähde S; Kinnula V
Am J Respir Crit Care Med; 1999 Mar; 159(3):818-23. PubMed ID: 10051256
[TBL] [Abstract][Full Text] [Related]
10. Exposure to commonly prescribed drugs and the etiology of cryptogenic fibrosing alveolitis: a case-control study.
Hubbard R; Venn A; Smith C; Cooper M; Johnston I; Britton J
Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):743-7. PubMed ID: 9517585
[TBL] [Abstract][Full Text] [Related]
11. Accuracy of the typical computed tomographic appearances of fibrosing alveolitis.
Tung KT; Wells AU; Rubens MB; Kirk JM; du Bois RM; Hansell DM
Thorax; 1993 Apr; 48(4):334-8. PubMed ID: 8135910
[TBL] [Abstract][Full Text] [Related]
12. Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study.
Hubbard R; Venn A; Lewis S; Britton J
Am J Respir Crit Care Med; 2000 Jan; 161(1):5-8. PubMed ID: 10619790
[TBL] [Abstract][Full Text] [Related]
13. Rising mortality from cryptogenic fibrosing alveolitis.
Johnston I; Britton J; Kinnear W; Logan R
BMJ; 1990 Nov; 301(6759):1017-21. PubMed ID: 2249048
[TBL] [Abstract][Full Text] [Related]
14. Asbestosis and cryptogenic fibrosing alveolitis: a radiological and functional comparison.
Cookson WO; Musk AW; Glancy JJ
Aust N Z J Med; 1984 Oct; 14(5):626-30. PubMed ID: 6597709
[TBL] [Abstract][Full Text] [Related]
15. Accuracy of diagnostic coding of hospital admissions for cryptogenic fibrosing alveolitis.
Johnston ID; Bleasdale C; Hind CR; Woodcock AA
Thorax; 1991 Aug; 46(8):589-91. PubMed ID: 1926030
[TBL] [Abstract][Full Text] [Related]
16. The predictive value of appearances on thin-section computed tomography in fibrosing alveolitis.
Wells AU; Hansell DM; Rubens MB; Cullinan P; Black CM; du Bois RM
Am Rev Respir Dis; 1993 Oct; 148(4 Pt 1):1076-82. PubMed ID: 8214928
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil activation in fibrosing alveolitis: a comparison of lone cryptogenic fibrosing alveolitis and systemic sclerosis.
Cailes JB; O'Connor C; Pantelidis P; Southcott AM; Fitzgerald MX; Black CM; du Bois RM
Eur Respir J; 1996 May; 9(5):992-9. PubMed ID: 8793462
[TBL] [Abstract][Full Text] [Related]
18. Expression of tumour necrosis factor-alpha in cryptogenic fibrosing alveolitis.
Nash JR; McLaughlin PJ; Butcher D; Corrin B
Histopathology; 1993 Apr; 22(4):343-7. PubMed ID: 8514277
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast chemotactic response elicited by native bronchoalveolar lavage fluid from patients with fibrosing alveolitis.
Behr J; Adelmann-Grill BC; Krombach F; Beinert T; Schwaiblmair M; Fruhmann G
Thorax; 1993 Jul; 48(7):736-42. PubMed ID: 8153923
[TBL] [Abstract][Full Text] [Related]
20. Increases in HLA-DQ, DP, DR, and transferrin receptors on alveolar macrophages in sarcoidosis and allergic alveolitis compared with fibrosing alveolitis.
Haslam PL; Parker DJ; Townsend PJ
Chest; 1990 Mar; 97(3):651-61. PubMed ID: 2306967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
